Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC35657107194;107195;107196 chr2:178528782;178528781;178528780chr2:179393509;179393508;179393507
N2AB34016102271;102272;102273 chr2:178528782;178528781;178528780chr2:179393509;179393508;179393507
N2A3308999490;99491;99492 chr2:178528782;178528781;178528780chr2:179393509;179393508;179393507
N2B2659279999;80000;80001 chr2:178528782;178528781;178528780chr2:179393509;179393508;179393507
Novex-12671780374;80375;80376 chr2:178528782;178528781;178528780chr2:179393509;179393508;179393507
Novex-22678480575;80576;80577 chr2:178528782;178528781;178528780chr2:179393509;179393508;179393507
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: G
  • RefSeq wild type transcript codon: GGC
  • RefSeq wild type template codon: CCG
  • Domain: Ig-167
  • Domain position: 51
  • Structural Position: 131
  • Q(SASA): 0.474
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
G/D None None 1.0 N 0.613 0.533 0.171388866994 gnomAD-4.0.0 1.59445E-06 None None None None N None 0 0 None 0 0 None 0 0 2.86623E-06 0 0
G/S rs2154131322 None 1.0 N 0.618 0.497 0.152612264143 gnomAD-4.0.0 1.59416E-06 None None None None N None 0 0 None 0 0 None 0 0 2.86569E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
G/A 0.2859 likely_benign 0.2802 benign -0.255 Destabilizing 1.0 D 0.555 neutral N 0.465852251 None None N
G/C 0.6021 likely_pathogenic 0.6054 pathogenic -0.966 Destabilizing 1.0 D 0.663 neutral N 0.46706576 None None N
G/D 0.3966 ambiguous 0.3871 ambiguous -0.427 Destabilizing 1.0 D 0.613 neutral N 0.46394531 None None N
G/E 0.4192 ambiguous 0.4076 ambiguous -0.577 Destabilizing 1.0 D 0.646 neutral None None None None N
G/F 0.8493 likely_pathogenic 0.8437 pathogenic -0.979 Destabilizing 1.0 D 0.647 neutral None None None None N
G/H 0.6798 likely_pathogenic 0.6746 pathogenic -0.301 Destabilizing 1.0 D 0.619 neutral None None None None N
G/I 0.6609 likely_pathogenic 0.6568 pathogenic -0.508 Destabilizing 1.0 D 0.651 neutral None None None None N
G/K 0.6136 likely_pathogenic 0.6231 pathogenic -0.542 Destabilizing 1.0 D 0.646 neutral None None None None N
G/L 0.7543 likely_pathogenic 0.7429 pathogenic -0.508 Destabilizing 1.0 D 0.673 neutral None None None None N
G/M 0.8291 likely_pathogenic 0.8161 pathogenic -0.621 Destabilizing 1.0 D 0.655 neutral None None None None N
G/N 0.492 ambiguous 0.4689 ambiguous -0.309 Destabilizing 1.0 D 0.611 neutral None None None None N
G/P 0.9181 likely_pathogenic 0.919 pathogenic -0.4 Destabilizing 1.0 D 0.643 neutral None None None None N
G/Q 0.547 ambiguous 0.5411 ambiguous -0.55 Destabilizing 1.0 D 0.639 neutral None None None None N
G/R 0.4422 ambiguous 0.4481 ambiguous -0.168 Destabilizing 1.0 D 0.637 neutral N 0.465852251 None None N
G/S 0.1683 likely_benign 0.1624 benign -0.479 Destabilizing 1.0 D 0.618 neutral N 0.464465385 None None N
G/T 0.4528 ambiguous 0.4464 ambiguous -0.561 Destabilizing 1.0 D 0.645 neutral None None None None N
G/V 0.5168 ambiguous 0.5044 ambiguous -0.4 Destabilizing 1.0 D 0.671 neutral N 0.466719043 None None N
G/W 0.7354 likely_pathogenic 0.741 pathogenic -1.063 Destabilizing 1.0 D 0.635 neutral None None None None N
G/Y 0.7613 likely_pathogenic 0.7549 pathogenic -0.762 Destabilizing 1.0 D 0.645 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.